Peer-reviewedCC BYMedical sciences (Basel, Switzerland)
Prognostic Significance of CD47 and DHX9 in Metastatic Rectal Cancer
- 1Department of Medical Oncology, Giresun Training and Research Hospital, 28100 Giresun, Turkey
- 2Department of Medical Oncology, Faculty of Medicine, , 01330 Saricam, Turkey
- 3Department of Pathology, Faculty of Medicine, , 01330 Saricam, Turkey
Related
- Receptor Status Changes, HER2-Low Discordance, and TNBC Transformation in Metastatic Breast Cancer: Prognostic Significance and Impact on Survival Outcomes
- Prevalence and Prognostic Significance of Positron Emission Tomography–Computed Tomography–Defined Low Skeletal Muscle Mass (Radiological Sarcopenia) in Metastatic Breast Cancer
- Prognostic significance and clinicopathologic prediction of tumor deposits in non-metastatic colon mucinous adenocarcinoma
- Prognostic significance of CCT5 in breast cancer and its regulatory mechanisms in promoting tumorigenesis
- Prognostic Significance of p53 Immunohistochemical Expression and Molecular Characterization of TP53 Variants in Triple-Negative Breast Cancer After Neoadjuvant Chemotherapy
BibTeX
@article{yaslikaya2026prognostic,
title = {{Prognostic Significance of CD47 and DHX9 in Metastatic Rectal Cancer}},
author = {Sendag Yaslikaya and Suheda Atas Ipek and Tugba Toyran and Ertugrul Bayram and Ismail Oguz Kara},
journal = {Medical sciences (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13707033},
note = {CC BY},
}
RIS
TY - JOUR
TI - Prognostic Significance of CD47 and DHX9 in Metastatic Rectal Cancer
AU - Sendag Yaslikaya
AU - Suheda Atas Ipek
AU - Tugba Toyran
AU - Ertugrul Bayram
AU - Ismail Oguz Kara
PY - 2026
DA - 2026/10/01
JO - Medical sciences (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13707033
SN - 2076-3271
ER -